Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (291-300 of 494) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2013
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibitionElisabeth Wik, Even Birkeland, Jone Trovik, et al.
The Oncologist|April 1, 2026
Time dependent outcomes modeling in a real-world analysis of the molecular tumor board at university cancer center Hamburg (2016-2022)Janna-Lisa Velthaus-Rusik, Jan Frederic Weller, Melisa Hoshaber, et al.
Cancers|September 9, 2022
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell CancerEike Burandt, Niclas C Blessin, Ann-Christin Rolschewski, et al.
Pathology International|April 22, 2020
Upregulation of PTTG1 is associated with poor prognosis in prostate cancerChristoph Fraune, Serhiy Yehorov, Andreas M Luebke, et al.
Human Pathology|October 7, 2008
Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel diseaseAndreas Marx, Timo Wandrey, Philipp Simon, et al.
Urologic Oncology|August 19, 2014
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarraysStefan Steurer, Julius Magnus Singer, Michael Rink, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
European Urology|July 13, 2014
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancerStefan Steurer, Pascale Sophia Mayer, Meike Adam, et al.
Clinical Chemistry|January 16, 2023
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal AdenocarcinomaChristine Nitschke, Benedikt Markmann, Philipp Walter, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Pageof 50

Showing results (291-300 of 494) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2013
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibitionElisabeth Wik, Even Birkeland, Jone Trovik, et al.
The Oncologist|April 1, 2026
Time dependent outcomes modeling in a real-world analysis of the molecular tumor board at university cancer center Hamburg (2016-2022)Janna-Lisa Velthaus-Rusik, Jan Frederic Weller, Melisa Hoshaber, et al.
Cancers|September 9, 2022
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell CancerEike Burandt, Niclas C Blessin, Ann-Christin Rolschewski, et al.
Pathology International|April 22, 2020
Upregulation of PTTG1 is associated with poor prognosis in prostate cancerChristoph Fraune, Serhiy Yehorov, Andreas M Luebke, et al.
Human Pathology|October 7, 2008
Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel diseaseAndreas Marx, Timo Wandrey, Philipp Simon, et al.
Urologic Oncology|August 19, 2014
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarraysStefan Steurer, Julius Magnus Singer, Michael Rink, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
European Urology|July 13, 2014
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancerStefan Steurer, Pascale Sophia Mayer, Meike Adam, et al.
Clinical Chemistry|January 16, 2023
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal AdenocarcinomaChristine Nitschke, Benedikt Markmann, Philipp Walter, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Pageof 50